App.okctulsaomd.com

STATE OF OKLAHOMA
2013 EMERGENCY MEDICAL SERVICES PROTOCOLS
16A – ALBUTEROL (PROVENTIL®, VENTOLIN®)
EMERGENCY MEDICAL
DISPATCHER
Self-Administration Phone Directive - 3B 3C 3D 12B EMERGENCY MEDICAL
Assist Pt with Self Administration - 3B 3C 3D 12B RESPONDER
EMT-INTERMEDIATE 85
ADVANCED EMT
PARAMEDIC

Class:
Sympathomimetic Bronchodilator

Actions/Pharmacodynamics:
Albuterol is a relatively selective beta2 adrenergic stimulant.
Albuterol causes relaxation of the smooth muscles of the bronchial tree thus decreasing airway resistance, facilitating mucus drainage, and increasing vital capacity. It exerts mild effects on beta1 (heart) or alpha (peripheral vasculature) receptors. In therapeutic doses, albuterol, by inhibiting histamine release from mast cells, also reduces the mucus secretion, capil ary leaking, and mucosal edema caused by an allergic response in the lungs.
Indications: Dyspnea - Uncertain Etiology (3B)
Dyspnea - Chronic Obstructive Pulmonary Disease (3D) Contraindications: Known hypersensitivity to albuterol. Albuterol should not be used if the
sole etiology of dyspnea is strongly suspected to be CHF, as albuterol-induced tachycardia may worsen the compromised cardiac output in CHF.
Pharmacokinetics: Onset within 5 – 15 minutes; peak effect in 1 – 1.5 hours; duration of effect
is up to 3 – 6 hours; half – life is less than 3 hours. Distribution: When inhaled, albuterol is distributed to muscle cells along the bronchial tree. Very little is systemically absorbed and Side Effects: Tremors, anxiety, dizziness, headache, cough, reflex bronchospasm, palpitations,
STATE OF OKLAHOMA
2013 EMERGENCY MEDICAL SERVICES PROTOCOLS

PROTOCOL 16A: Albuterol (Proventil®, Ventolin®)
Dyspnea - Uncertain Etiology - Adult & Pediatric Weight ≥ 15kg (3B)
Smoke Inhalation - Adult & Pediatric Weight ≥ 15kg (12B)
Dyspnea - Uncertain Etiology - Pediatric Weight < 15kg (3B)
Smoke Inhalation - Pediatric Weight < 15kg (12B)
Dyspnea - Asthma - Adult & Pediatric Weight ≥ 15kg (3C)
Dyspnea - Chronic Obstructive Pulmonary Disease - Adult (3D)
Acute Allergic Reactions - Adult & Pediatric Weight ≥ 15kg (8D)
Bee/Wasp Stings - Adult & Pediatric Weight ≥ 15kg (8F)
5mg nebulized (with ipratropium bromide 0.5mg), may repeat twice Dyspnea - Asthma - Pediatric Weight < 15kg (3C)
Acute Allergic Reactions - Pediatric Weight < 15kg (8D)
Bee/Wasp Stings - Pediatric Weight < 15kg (8F)
2.5mg nebulized (with ipratropium bromide 0.25mg), may repeat twice How Supplied:
2.5 mg/ 3 mL (0.083%) in nebulizer vials. (Always check concentration and dose per container at time of patient

Source: http://app.okctulsaomd.com/src/16A_Albuterol-Proventil-Ventolin.pdf

Regulation of the european parliament and of the council

GA Alliance Position Paper in respect of COM(2005) 429 final 2005/0191 (COD) Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on common rules in the field of civil aviation security Introduction The EC has proposed to implement a new Regulation to impose security requirements on airports and flight crew which, if approved in their current drafted st

drnsrl.it

Veterinaria, Anno 20, n. …, … 2006 USO DI UNA DIETA INDUSTRIALE DI QUAGLIA (SOLO QUAGLIA® DRN) NELL’ITER DIAGNOSTICO DELLE DERMATITI PRURIGINOSE DI ORIGINE ALLERGICA NEL CANE E NEL GATTO: RISULTATI PRELIMINARI LUISA CORNEGLIANI*, GIOVANNI GHIBAUDO§, STEFANO TOMA‡ *Ambulatorio Veterinario Associato, C.so Traiano 99/d, 10135 Torino§Clinica Veterinaria Malpensa, Via M

Copyright © 2011-2018 Health Abstracts